Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Selegiline hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Selegiline 5mg tablets
0409010T0AAAAAA
|
Selegiline hydrochloride | Selegiline hydrochloride | Central Nervous System | 2,453 |
|
Selegiline 10mg tablets
0409010T0AAACAC
|
Selegiline hydrochloride | Selegiline hydrochloride | Central Nervous System | 2,318 |
|
Selegiline 1.25mg oral lyophilisates sugar free
0409010T0AAAKAK
|
Selegiline hydrochloride | Selegiline hydrochloride | Central Nervous System | 6 |
|
Selegiline 10mg/5ml oral solution
0409010T0AAALAL
|
Selegiline hydrochloride | Selegiline hydrochloride | Central Nervous System | 3 |
|
Selegiline 19mg/5ml oral solution
0409010T0AAAIAI
|
Selegiline hydrochloride | Selegiline hydrochloride | Central Nervous System | No data available |
|
Selegiline 5mg/5ml oral solution
0409010T0AAAGAG
|
Selegiline hydrochloride | Selegiline hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.